Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis.

Mureidomycin A (MRD), a novel peptidylnucleoside antibiotic with antipseudomonal activity, inhibited not only peptidoglycan synthesis but also lipid-intermediate formation from UDP-N-acetylmuramyl (MurNAc)-pentapeptide and UDP-N-acetylglucosamine in an in vitro peptidoglycan-synthesizing system, usi...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Isono, F, Inukai, M
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 1991
主題:	Research Article
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC244983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1902646/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.234
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!